Welcome to NextGen Pharma Pvt. Ltd.

At NextGen Pharma, we believe that the key to enhancing health and happiness lies within us and that it can be powered through innovation. This belief is what inspires us and fuels our every endeavour. As a healthcare entity, we strive to add new dimensions to prevention, management and promoting wellness through evidence-based specialty probiotics. Our team of researchers and specialists spare no effort to comprehend therapy gaps and devise ways to bridge them through products that are backed by robust and state-of-the-art trials. In our efforts to create a legacy of superior and safer therapies, we are dedicated to develop, produce and deliver clinically proven healthcare solutions that not only alleviate pain and suffering but also propels life towards well-being. A majority-owned subsidiary of Ormendes SA, Switzerland, today, NextGen Pharma is a leading provider of proprietary Targeted Bacterio-Therapy (TBT) for healthcare partners in diverse therapeutic segments ranging from Gastrointestinal to Neurology, with presence spanning across ASEAN, Middle East, CIS and now working towards expansion into Africa. With our proven track record in Targeted Bacterio-therapy (TBT), we are helping partners enter niche therapy areas where there are limited or no therapies available. Our products are either single strains of specific bacteria or proprietary blends of specific strains of bacteria chosen for specific indications. The efficacy of the formulations using these specific bacterial composition are then validated through comprehensive preclinical and clinical trials. Making use of established research procedures to develop evidence-inspired formulations, proven probiotics; and scientifically certified solutions. Thus, we deliver them with the much needed competitive edge they deserve over existing similar therapies.